Yumanity Therapeutics, Inc. reported earnings results for the year ended December 31, 2020. For the year, the company reported Collaboration revenue of $6,896,000. Loss from operations was $55,631,000 against $30,031,000 a year ago. Net loss was $57,487,000 or $21.57 per basic and diluted share against $31,209,000 or $14.71 per basic and diluted share a year ago.